Related Experiment Videos
Individuals' responses to global CHD risk: a focus group study
Stacey L Sheridan1, Lindy Behrend, Maihan B Vu
1Division of General Medicine and Clinical Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7110, USA. rolf.wynn@gmail.com
Patient Education and Counseling
|March 17, 2009
Summary
Global coronary heart disease (CHD) risk information can motivate individuals to adopt risk-reducing strategies. Patient involvement in decision-making is crucial for effective CHD prevention and management.
Area of Science:
- Cardiovascular Health
- Behavioral Science
- Health Decision-Making
Background:
- Coronary heart disease (CHD) poses a significant global health burden.
- Understanding patient perception of risk is vital for effective prevention strategies.
Purpose of the Study:
- To investigate how individuals perceive and utilize global CHD risk information.
- To explore the role of risk information and treatment details in decision-making for risk reduction.
Main Methods:
- Four focus groups were conducted with 29 individuals at risk for CHD.
- Verbatim transcripts were analyzed using qualitative coding methods with ATLAS.ti software.
Main Results:
- Participants found global CHD risk information useful and motivating, despite some concerns about precision.
- Key decision-making factors included achievable risk, speed of results, and preference for lifestyle changes over medication.
- Patient participation in decision-making was highlighted as important.
Conclusions:
- Global CHD risk assessment is a valuable tool for motivating CHD prevention efforts.
- Tailoring the presentation of risk information and emphasizing patient involvement can enhance CHD outcomes.
Related Concept Videos
01:23Assessment of the Cardiovascular System I: Subjective Data
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:20Lifestyle Factors and Health
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...